Quality by Design: Reagents and Support for hPSC-Derived Cell and Gene Therapies

Each year, more human pluripotent stem cell-derived (hPSC-derived) therapies move towards the clinic, and STEMCELL is committed to supporting researchers from discovery to clinical application. In this Innovation Showcase from ISSCR 2021, Lynn Csontos will demonstrate how we build quality into our products, processes, and policies to support your project timing, product quality, and overall vision. Kimberly Snyder will then present data that shows how TeSR™-AOF, a novel animal origin-free (AOF) hPSC maintenance medium, can support optimized cell quality, improved performance and reproducibility across all cell lines.

As a supporter of, and participant in, ISSCR’s 2021 Annual Meeting, we share with you our Innovation Showcase presentation at #ISSCR2021.
This presentation does not represent an endorsement from or support of the ISSCR.
Publish Date: August 16, 2021 Views: 0

Contact STEMCELL Technologies

Our Customer Service, Sales, and Product and Scientific Support departments in North America are available between 6 am and 5 pm Pacific Time (9 am and 8 pm Eastern Time). One of our representatives will be happy to help you by telephone or email. Please complete the form to contact us by email. A representative will get back to you shortly.

StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not share your email address with third parties. StemCell Technologies Inc. will use your email address to confirm your identity and send you newsletters, transaction-related emails, promotional and customer service emails in accordance with our privacy policy. You can change your email preferences at any time.